Nanocrystal News and Research

RSS
Scientists develop super-sensitive test that could detect diseases earlier

Scientists develop super-sensitive test that could detect diseases earlier

ACS symposium focuses on biomimetics

ACS symposium focuses on biomimetics

New process can create LEDs that produce light in the UV range

New process can create LEDs that produce light in the UV range

Elan fourth quarter total revenue increases 18% to $271.0 million

Elan fourth quarter total revenue increases 18% to $271.0 million

Elan's third quarter total revenue increases 17% to $328.5 million

Elan's third quarter total revenue increases 17% to $328.5 million

Decline of citrate concentration may contribute to bone brittleness

Decline of citrate concentration may contribute to bone brittleness

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Elan Drug Technologies, Alkermes merge to form new company in Ireland

EDT receives European approval for XEPLION injection to treat schizophrenia

EDT receives European approval for XEPLION injection to treat schizophrenia

Elan 2010 total revenue increases 5% to $1,169.7 million

Elan 2010 total revenue increases 5% to $1,169.7 million

Life Technologies announces early stage results from SMS technology

Life Technologies announces early stage results from SMS technology

Elan announces fourth-quarter and full-year financial results ended December 31, 2009

Elan announces fourth-quarter and full-year financial results ended December 31, 2009

Elan Drug Technologies issues statement on FDA approval of AMPYRA

Elan Drug Technologies issues statement on FDA approval of AMPYRA

Approval of injectable formulation using NanoCrystal technology announced

Approval of injectable formulation using NanoCrystal technology announced

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Janssen-Cilag submits MAA to the European Medicines Agency for paliperidone palmitate

Janssen-Cilag submits MAA to the European Medicines Agency for paliperidone palmitate

Elan announces fiscal 2009 third-quarter results

Elan announces fiscal 2009 third-quarter results

Bio-friendly nanocrystals allow study of biomolecules one at a time

Bio-friendly nanocrystals allow study of biomolecules one at a time

AstraZeneca and MAP Pharmaceuticals announce collaboration on Unit Dose Budesonide

AstraZeneca and MAP Pharmaceuticals announce collaboration on Unit Dose Budesonide

New method for detecting HER2 breast cancer

New method for detecting HER2 breast cancer

Nanocrystal research for cellulose drug delivery

Nanocrystal research for cellulose drug delivery